Market Cap (In CNY)
5.6 Billion
Revenue (In CNY)
1.61 Billion
Net Income (In CNY)
292.7 Million
Avg. Volume
7.4 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 10.69-20.06
- PE
- -
- EPS
- -
- Beta Value
- 0.829
- ISIN
- CNE1000040B4
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Hai Zhang
- Employee Count
- -
- Website
- https://www.gz-sanli.com
- Ipo Date
- 2020-04-28
- Details
- GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.
More Stocks
-
PANABYTEPANABYTE TECHNOLOGIES LIMITED
PANABYTE
-
HEIQHeiQ Plc
HEIQ
-
601233Tongkun Group Co., Ltd.
601233
-
SOSSosandar Plc
SOS
-
PIKKidpik Corp.
PIK
-
DUN
-
HASTIFINHasti Finance Limited
HASTIFIN
-
002841